Febuxostat
| CAS No. | 144060-53-7 |
|---|---|
| MDL No. | MFCD00871598 |
| MF | C16H16N2O3S |
| MW | 316.40 |
| InChI Key | BQSJTQLCZDPROO-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Febuxostat is a 1,3-thiazolemonocarboxylic acid, specifically 4-methyl-1,3-thiazole-5-carboxylic acid substituted with a 3-cyano-4-(2-methylpropoxy)phenyl group at position 2. It is an orally active, potent, and selective xanthine oxidase inhibitor used to treat chronic hyperuricaemia in gout patients. It functions as an EC 1.17.3.2 (xanthine oxidase) inhibitor and is classified as an aromatic ether, a nitrile, and a 1,3-thiazolemonocarboxylic acid.
| CAS No. | 144060-53-7 |
|---|---|
| Product Name | Febuxostat |
Biological Targets
XDH
Associated Conditions
gout·nephrolithiasis·hypertension·Tumor Lysis Syndrome·cardiovascular disease·
* The information provided here is compiled from public sources and is for reference only.
